Press Releases Current page: 4

The medtech zwo magazine reported on the participation of SHS Tübingen in the endoscopy manufacturer Blazejewski MEDI-Tech GmbH from Sexau. The company develops and produces endoscopes and endoscopy cameras. Within the scope of a partnership with the lighting specialist Photonic, the visual characteristics of the endoscopes are being improved, which also offers enormous potential for […]

In January, the Handelsblatt reported on the current financing round of Selfapy, a psychotherapy start-up that wants to make better and faster psychotherapy treatment possible with its app. Selfapy offers online courses for the treatment of burnout, depression, anxiety and eating disorders. Selfapy hopes that the new German digital care law (DVG) will make their […]

In an interview with Hubertus Leonhardt, managing director and partner of SHS, and Manfred Ulmer-Weber, investment manager and partner at SHS, VC Magazin reports on the development of the company and its current fifth fund (SHS V). SHS Tübingen has developed into one of the largest industry specialists in the medical technology and life science […]

The medtech zwo magazine reports on developments in robot-assisted surgery. The SHS portfolio company AOT has developed an innovative procedure for bone surgery with its laser osteotomy robot Carlo. The robot is able to perform complicated operations on the bone independently under the supervision of a surgeon using a new type of laser cutting process. […]

medtech zwo magazine spoke in an interview with Hubertus Leonhardt, Managing Director and Partner of SHS, about the current situation in the medical technology sector. The SHS Medical Technology Index, which was developed in cooperation between Christan Koziol, Professor and Chair of Finance at the University of Tübingen, and SHS, quantifies developments and industry trends. […]

The Börsen-Zeitung covers the publication of the SHS-Medtech-Index and reports on new developments in the industry, with the Medical Device Regulation being a crucial topic. In light of stagnant numbers of patent approvals per year in the Medtech industry, Hubertus Leonhardt is cited by the newspaper. The Managing Partner of SHS states that there is […]

The Frankfurter Allgemeine Zeitung reports about the newly issued SHS-Medtech-Index, which was jointly developed by Christian Koziol, Head of the Finance Department of the University of Tübingen, and SHS. The index measures the development of the German Medtech industry in relation to the overall economy since 2010. Four indicators are used: revenue, working population, patents […]

Die Basler Zeitung berichtet über eine Weltpremiere: Die erste Operation, bei der menschlicher Knochen ausschließlich mit einem robotergesteuerten Laser geschnitten wurde. Philipp Jürgens, leitender Arzt in der Mund-, Kiefer- und Gesichtschirurgie am Universitätsspital Basel, sieht das Potenzial „die Knochenchirurgie zu revolutionieren“. Das innovative Verfahren basiert auf Carlo, einem Laser-Osteotomie Roboter, entwickelt vom SHS-Portfoliounternehmen AOT. Carlo […]

The Venture Capital magazine examines the price level of buyout transactions this spring, with a special focus on medical technology. Experts classify the industry as very promising, but rate the prices as often not justified. Hubertus Leonhardt, Managing Partner at SHS Gesellschaft für Beteiligungsmanagement mbH, points out that buyout transactions are often about more than […]

WirtschaftsWoche reports on the third investment of SHS from its current fund SHS V. Betterguards Technology GmbH, founded in 2014 and headquartered in Berlin with a production facility in Brandenburg, develops and produces intelligent components (so-called adaptors) that can be integrated into sports shoes, bandages or work protection shoes, for example. Equipped with this unique […]

c-LEcta, an innovative SHS portfolio company in the field of white biotechnology, reports in the Süddeutsche Zeitung on how its enzymes are used to produce new sweeteners based on the stevia plant. The sweeteners developed jointly with industrial partners already have FDA approval in the USA, where sugar substitutes are used in beverages and food. […]

The private equity news portal Unquote evaluates the effects of the new German Scheduling and Supply Act and refers to the opportunities and risks of the global medical technology market. Despite tougher regulations, experts do not expect an economic slowdown for the medical technology, life science and biotechnology industries. Dr. Andre Zimmermann, Partner at SHS […]